Publications by authors named "James Hadley"

Claim this Profile
T
The Current Accuracy, Cost-Effectiveness, and Uses of Musculoskeletal Telehealth and Telerehabilitation Services.
Katherine Rennie, Charles Taylor, Anna Chiara Corriero, Collin Chong, Edward Sewell, James Hadley

Curr Sports Med Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant orbital and intracranial complications from balloon sinus dilation as a stand-alone and powered dissector-assisted procedure.
Elie S Alam, James A Hadley, Jeb M Justice, Roy R Casiano

Laryngoscope· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys.
Leonard Bielory, David P Skoner, Michael S Blaiss, Bryan Leatherman, Mark S Dykewicz, James A Hadley

Allergy Asthma Proc· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy.
Bryan Leatherman, David P Skoner, James A Hadley, Nicole Walstein, Michael S Blaiss

Int Forum Allergy Rhinol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin prick/puncture testing in North America: a call for standards and consistency.
Shahnaz Fatteh, Donna J Rekkerth, James A Hadley

Allergy Asthma Clin Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria Headache.
Annette C Douglas, Franz J Wippold, Daniel F Broderick, Ashley H Aiken, Sepideh Amin-Hanjani, James A Hadley

J Am Coll Radiol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
William E Berger, Shailen Shah, Phil Lieberman, James Hadley, David Price

J Allergy Clin Immunol Pract· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.
Eli Meltzer, Paul Ratner, Claus Bachert, Warner Carr, William Berger, James Hadley

Int Arch Allergy Immunol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and allergic rhinitis: not just a runny nose.
James A Hadley, M Jennifer Derebery, Bradley F Marple

J Fam Pract· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Closing thoughts: implications of the findings from the National Allergy Survey Assessing Limitations for the management of allergic rhinitis in America.
Stuart W Stoloff, James A Hadley, Eli O Meltzer

J Fam Pract· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Otoscopic signs of otitis media.
Nader Shaikh, Alejandro Hoberman, Phillip H Kaleida, Howard E Rockette, Marcia Kurs-Lasky, James A Hadley

Pediatr Infect Dis J· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.
James A Hadley, Ralph Mösges, Martin Desrosiers, Daniel Haverstock, David van Veenhuyzen

Laryngoscope· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician perspectives on the attributes of nasal allergy medications.
Robert M Naclerio, James A Hadley, Stuart Stoloff, Harold S Nelson

Allergy Asthma Proc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal corticosteroids in the treatment of allergic rhinitis.
Paul H Ratner, Stuart Stoloff, Eli O Meltzer, James A Hadley

Allergy Asthma Proc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing rhinitis: Strategies for improved patient outcomes.
Warner W Carr, Michael R Nelson, James A Hadley

Allergy Asthma Proc· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cephalosporin use in treatment of patients with penicillin allergies.
Daryl D DePestel, Michael S Benninger, Larry Danziger, Kerry L LaPlante, Chandler May, James A Hadley

J Am Pharm Assoc (2003)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks.
Jennifer H Anolik, Rajan Ravikumar, Jennifer Barnard, Teresa Owen, Anthony Almudevar, James A Hadley

J Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of newer orally administered cephalosporins in contemporary outpatient practice.
James A Hadley, Thomas R Fritsche

Diagn Microbiol Infect Dis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral beta-lactams in the treatment of acute bacterial rhinosinusitis.
James A Hadley, Michael A Pfaller

Diagn Microbiol Infect Dis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.
James A Hadley, Glenn S Tillotson, Robert Tosiello, Roger M Echols

Expert Rev Anti Infect Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhinosinusitis: Developing guidance for clinical trials.
Eli O Meltzer, Daniel L Hamilos, James A Hadley, Donald C Lanza, Bradley F Marple

Otolaryngol Head Neck Surg· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhinosinusitis: developing guidance for clinical trials.
Eli O Meltzer, Daniel L Hamilos, James A Hadley, Donald C Lanza, Bradley F Marple

J Allergy Clin Immunol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of cefdinir in acute bacterial rhinosinusitis.
James A Hadley

Expert Opin Pharmacother· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis.
Michael S Benninger, Spencer C Payne, Berrylin J Ferguson, James A Hadley, Nadir Ahmad

Otolaryngol Head Neck Surg· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis.
James A Hadley

Int J Antimicrob Agents· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis